Report copyright - A Randomized Trial of Dabigatran, a Oral Direct Thrombin Inhibitor, Compared to Warfarin in 18,113 Patients With Atrial Fibrillation at High Risk of Stroke (RE-LY) – Stuart J. Connolly
Please pass captcha verification before submit form